LSL Pharma Group Inc. (TSXV:LSL)
0.3100
+0.0050 (1.64%)
Jun 30, 2026, 2:35 PM EST
-22.50% (1Y)
| Market Cap | 38.18M -15.3% |
| Revenue (ttm) | 26.80M +69.4% |
| Net Income | 2.78M |
| EPS | 0.02 |
| Shares Out | 121.22M |
| PE Ratio | 13.88 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,000 |
| Open | 0.3150 |
| Previous Close | 0.3050 |
| Day's Range | 0.3100 - 0.3150 |
| 52-Week Range | 0.3000 - 0.5600 |
| Beta | -0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 20, 2026 |